Home » Topics » BioWorld Science

BioWorld Science
RSS

Company Profile: Megabios

Nov. 21, 1996

Approval recommended for Elan's gel formulation of diazepam

Nov. 21, 1996

Taxotere approved in three additional markets

Nov. 21, 1996

First regulatory approval for impotence treatment

Nov. 21, 1996

First filing for Imutec's Virulizin

Nov. 21, 1996

SIBIA Neurosciences reports preclinical results with NAChR-selective compounds

Nov. 21, 1996

Thalidomide clinical trials in brain cancer expanded

Nov. 21, 1996

Thrombopoietic activity of PEG-rHuMGDF established in cancer patients

Nov. 21, 1996

NIH to conduct clinical trial of Ampalex in AD

Nov. 21, 1996

Pharmagenesis and Lilly collaborate on development of antifungal agents

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...